Page 121 - 80_01

Class
I
phosphoinositide
3-­-kinases
in
immunity…

71.
Alcazar,
I.;
Cortes,
I.;
Zaballos,
A.;
Hernandez,
C.;
Fruman,
D.
A.;
Barber,
D.
F.;
&
Carrera,
A.
C.

p85ß
phosphoinositide
3-­-kinase
regulates
CD28
coreceptor
function.
Blood
113,
3198-­-
3208
(2009).

72.
Oak,
J.
S.;
Deane,
J.
A.;
Kharas,
M.
G.;
Luo,
J.;
Lane,
T.
E.;
Cantley,
L.
C.;
&
Fruman,
D.
A.

Sjögren's
syndrome-­-like
disease
in
mice
with
T
cells
lacking
class
1A
phosphoinositide-­-3-­-
kinase.
Proc
Natl
Acad
Sci
USA
103,
16882-­-16887
(2006).

73.
Deane,
J.
A.;
Kharas,
M.
G.;
Oak,
J.
S.;
Stiles,
L.
N.;
Luo,
J.;
Moore,
T.
I.;
Ji,
H.;
&
al.
T-­-cell

function
is
partially
maintained
in
the
absence
of
class
IA
phosphoinositide
3-­-kinase

signaling.
Blood
109,
2894-­-2902
(2007).

74.
Rolf,
J.;
Bell,
S.
E.;
Kovesdi,
D.;
Janas,
M.
L.;
Soond,
D.
R.;
Webb,
L.
M.
C.;
Santinelli,
S.;
&
al.

Phosphoinositide
3-­-kinase
activity
in
T
cells
regulates
the
magnitude
of
the
germinal

center
reaction.
J
Immunol
185,
4042-­-4052
(2010).

75.
Rodríguez-­-Borlado,
L.;
Barber,
D.
F.;
Hernández,
C.;
Rodríguez-­-Marcos,
M.
A.;
Sánchez,
A.;

Hirsch,
E.;
Wymann,
M.;
&
al.
Phosphatidylinositol
3-­-kinase
regulates
the
CD4/CD8
T
cell

differentiation
ratio.
J
Immunol
170,
4475-­-4482
(2003).

76.
Garçon,
F.;
Patton,
D.
T.;
Emery,
J.
L.;
Hirsch,
E.;
Rottapel,
R.;
Sasaki,
T.;
&
Okkenhaug,
K.

CD28
provides
T-­-cell
costimulation
and
enhances
PI3K
activity
at
the
immune
synapse

independently
of
its
capacity
to
interact
with
the
p85/p110
heterodimer.
Blood
111,

1464-­-1471
(2008).

77.
Thomas,
M.
S.;
Mitchell,
J.
S.;
DeNucci,
C.
C.;
Martin,
A.
L.;
&
Shimizu,
Y.
The
p110?
isoform
of

phosphatidylinositol
3-­-kinase
regulates
migration
of
effector
CD4
T
lymphocytes
into

peripheral
inflammatory
sites.
J
Leukoc
Biol
84,
814-­-823
(2008).

78.
Martin,
A.
L.;
Schwartz,
M.
D.;
Jameson,
S.
C.;
&
Shimizu,
Y.
Selective
regulation
of
CD8

effector
T
cell
migration
by
the
p110?
isoform
of
phosphatidylinositol
3-­-kinase.
J
Immunol

180,
2081-­-2088
(2008).

79.
Webb,
L.
M.
C.;
Vigorito,
E.;
Wymann,
M.
P.;
Hirsch,
E.;
&
Turner,
M.
Cutting
edge:
T
cell

development
requires
the
combined
activities
of
the
p110?
and
p110d
catalytic
isoforms

of
phosphatidylinositol
3-­-kinase.
J
Immunol
175,
2783-­-2787
(2005).

80.
Bilancio,
A.;
Okkenhaug,
K.;
Camps,
M.;
Emery,
J.
L.;
Ruckle,
T.;
Rommel,
C.;
&

Vanhaesebroeck,
B.
Key
role
of
the
p110d
isoform
of
PI3K
in
B-­-cell
antigen
and
IL-­-4

receptor
signaling:
comparative
analysis
of
genetic
and
pharmacologic
interference
with

p110d
function
in
B
cells.
Blood
107,
642-­-650
(2006).

81.
So,
L.;
Yea,
S.
S.;
Oak,
J.
S.;
Lu,
M.;
Manmadhan,
A.;
Ke,
Q.
H.;
Janes,
M.
R.;
&
al.
Selective

inhibition
of
phosphoinositide
3-­-kinase
p110a
preserves
lymphocyte
function.
J
Biol
Chem

288,
5718-­-5731
(2013).

82.
Aragoneses-­-Fenoll,
L.;
Montes-­-Casado,
M.;
Herranz,
J.;
Acosta,
Y.
Y.;
Martínez,
S.;
Blanco-­-
Aparicio,
C.;
Pastor,
J.;
&
al.
ETP-­-46321,
a
dual
p110a/d
class
IA
phosphoinositide
3-­-kinase

inhibitor
modulates
CD28
and
ICOS
costimulation
of
CD4+
T
lymphocyte
responses,
cell

survival,
and
immune
responses
in
vivo
(Submitted)

(2013).

83.
Shi,
J.;
Cinek,
T.;
Truitt,
K.
E.;
&
Imboden,
J.
B.
Wortmannin,
a
phosphatidylinositol
3-­-kinase

inhibitor,
blocks
antigen-­-mediated,
but
not
CD3
monoclonal
antibody-­-induced,
activation

of
murine
CD4+
T
cells.
J
Immunol
158,
4688-­-4695
(1997).

84.
Bain,
J.;
Plater,
L.;
Elliott,
M.;
Shpiro,
N.;
Hastie,
C.
J.;
McLauchlan,
H.;
Klevernic,
I.;
&
al.
The

selectivity
of
protein
kinase
inhibitors:
a
further
update.
Biochem
J
408,
297-­-315
(2007).

85.
Okkenhaug,
K.;
Patton,
D.
T.;
Bilancio,
A.;
Garcon,
F.;
Rowan,
W.
C.;
&
Vanhaesebroeck,
B.

The
p110d
isoform
of
phosphoinositide
3-­-kinase
controls
clonal
expansion
and

differentiation
of
Th
cells.
J
Immunol
177,
5122-­-5128
(2006).

86.
Haylock-­-Jacobs,
S.;
Comerford,
I.;
Bunting,
M.;
Kara,
E.;
Townley,
S.;
Klingler-­-Hoffmann,
M.;

Vanhaesebroeck,
B.;
&
al.
PI3Kd
drives
the
pathogenesis
of
experimental
autoimmune

encephalomyelitis
by
inhibiting
effector
T
cell
apoptosis
and
promoting
Th17

differentiation.
J
Autoimmun
36,
278-­-287
(2011).

87.
Soond,
D.
R.;
Bjorgo,
E.;
Moltu,
K.;
Dale,
V.
Q.;
Patton,
D.
T.;
Torgersen,
K.
M.;
Galleway,
F.;
&

al.
PI3K
p110d
regulates
T-­-cell
cytokine
production
during
primary
and
secondary

immune
responses
in
mice
and
humans.
Blood
115,
2203-­-2213
(2010).

88.
Rolf,
J.;
Fairfax,
K.;
&
Turner,
M.
Signaling
pathways
in
T
follicular
helper
cells.
J
Immunol

184,
6563-­-6568
(2010).

119